Research / ARDX / Fundamental state Inspectable configuration
State dimensions Filing 0001437402-25-000018 General Corporate
Debt relative to revenue 35th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
183.21% · OPTIONAL · VALID
Capex intensity 30th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
0.14% · OPTIONAL · VALID
Operating cash generation 95th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
0.33% · OPTIONAL · VALID
Revenue growth 20th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
12.30% · CORE · VALID
Inventory pressure 43th Own-history percentile · N=14
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
117.25% · OPTIONAL · VALID
Operating margin 95th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
4.23% · CORE · VALID
R&D intensity 20th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
16.38% · OPTIONAL · VALID
SBC intensity 20th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
11.55% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 32 states Self-history eligible
Sep 30, 2021 7/7 normalized Level 3 Dec 31, 2021 7/7 normalized Level 3 Mar 31, 2022 7/8 normalized Level 3 Jun 30, 2022 7/8 normalized Level 3 Sep 30, 2022 7/8 normalized Level 3 Dec 31, 2022 7/8 normalized Level 3 Mar 31, 2023 7/8 normalized Level 3 Jun 30, 2023 7/8 normalized Level 3 Sep 30, 2023 7/8 normalized Level 3 Dec 31, 2023 7/8 normalized Level 3 Mar 31, 2024 8/8 normalized Level 3 Jun 30, 2024 8/8 normalized Level 3 Sep 30, 2024 8/8 normalized Level 3 Dec 31, 2024 8/8 normalized Level 3 Mar 31, 2025 8/8 normalized Level 3 Jun 30, 2025 8/8 normalized Level 3 Sep 30, 2025 8/8 normalized Level 3 Dec 31, 2025 8/8 normalized Level 3 Mar 31, 2026 8/8 normalized Level 3 Jun 30, 2026 8/8 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 206.27%
Current 183.21%
Delta -23.05% Capex Intensity Decreased
Previous 0.67%
Current 0.14%
Delta -0.52% Cash Generation Increased
Previous -25.95%
Current 0.33%
Delta 26.28% Growth Decreased
Previous 33.38%
Current 12.30%
Delta -21.07% Inventory Pressure Decreased
Previous 126.21%
Current 117.25%
Delta -8.96% Profitability Increased
Previous -14.74%
Current 4.23%
Delta 18.97% R And D Intensity Increased
Previous 16.04%
Current 16.38%
Delta 0.33% Sbc Intensity Decreased
Previous 11.97%
Current 11.55%
Delta -0.42% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.